Molecular architecture of UQH2:cyt c2 oxidoreductase
Molecular architecture of UQH2:cyt c2 oxidoreductase
批准号:
7758747
负责人:
ANTONY R. CROFTS
金额:
$28.4万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2011-12-31
关键词:
AccountingAddressAgricultureAntimalarialsArchitectureAsphyxiaBehaviorBindingBiochemistryBiological AssayBiological ModelsBiologyBypassCatalytic DomainCell AgingCell physiologyCellsChemistryCollaborationsComplexComputer SimulationCoupledDataData SetDefectDependenceDevelopmentDrug Delivery SystemsElectron TransportElectronsElectrostaticsEngineeringEnvironmentEnzymesEvolutionExperimental ModelsFreezingGenerationsGlutamatesGrantHeadHemeHerbicidesIndustrial fungicideIron-Sulfur ProteinsKineticsLabelLeadLeftLigandsLightingLiteratureMaintenanceMeasuresMedicineMetabolismMicrofluidicsMitochondriaModelingMolecularMolecular MachinesMovementMutagenesisMutationOxidation-ReductionOxidoreductasePathway interactionsPest ControlPesticidesPharmaceutical PreparationsPhysiologic pulseProcessProductionPropertyProteinsQiQuinonesReactionReactive Oxygen SpeciesReagentResearchResearch SupportRespiratory ChainRhodobacter sphaeroidesRieske iron-sulfur proteinRoleShapesSiteSpectrophotometrySpectroscopy, Fourier Transform InfraredSpectrum AnalysisStructureSystemTestingThermodynamicsTimeTitrationsUbiquinoneWorkX-Ray Crystallographybasecytochrome cdesigndimerelectronic structureexperienceinhibitor/antagonistinsightinterestmonomermutantoperationoxidationphotosynthetic bacteriaprofessorresearch studyrespiratorysuccessvector
中文摘要
描述(由申请人提供):我们建议进一步研究Bc1复合体(UQH2:Cyt c2氧化还原酶)的机制,以了解它在细胞衰老中的作用,以及它作为药物和害虫防治试剂靶标的功能。后者依赖于在不同物种中作为抗疟疾药物、杀菌剂、杀虫剂、除草剂等的苯醌模拟物的不同敏感性。这些酶是所有主要呼吸和光合作用途径的核心,直接负责生物圈约30%的能量转换。生物学中的这一核心重要性提供了一种内在的兴趣,直接与我们对细胞生理学、能量转换机制和维护的理解有关。光合作用细菌为研究医学上重要的线粒体复合体提供了一个模型系统。BC1复合体的催化核心在线粒体-细菌分裂中高度保守,反应机制基本上是相同的。在细菌系统中,功能和结构之间的相互作用可以更容易地研究,因为该系统可以被光照激活,在10<;S时间尺度内启动周转。此外,细菌系统很容易通过特定的突变来适应分子工程。这笔赠款支持的研究为我们理解这些复合体的功能做出了很大贡献。我们利用35年在分析功能方面的经验,通过多管齐下的方法,利用分子工程、生物物理分析、X射线结晶学结构研究、通过光谱学对局部结构的详细分析以及通过计算机模拟进行建模,来探索这一机制。从这些研究中出现的复合体的分子结构为目前可用的这种复杂性的分子机器提供了最详细的描述之一。晶体结构的可获得性激发了人们的兴趣,并为我们提出的修改的Q循环提供了强有力的支持,这被普遍认为是潜在的机制。然而,这些结构也引发了一些有趣的问题,主要与意想不到的动态特征有关,包括大规模的结构域移动,以及更微妙的局部分子芭蕾,允许快速周转而不破坏旁路反应。在这项提案中,我们解决了一些更具争议性的问题,包括将导致细胞窒息的破坏性活性氧的前体的产生降至最低的机制的特征。该提案是为了继续研究新陈代谢的关键酶之一Bc1复合体(泛氢苯二酚-细胞色素c氧化还原酶)。线粒体通过代谢产物的氧化为细胞提供能量,利用呼吸链将电子传递给氧气。Bc1复合体是该链的中心酶。过去进化过程中的一个设计缺陷使这个复合体具有产生破坏性氧自由基的能力,从而损害细胞。我们在球形红杆菌中研究了同样的酶,这是一种与线粒体的细菌祖先很接近的光合细菌。由于酶可以通过光合作用机制被激活,因此更容易研究快速的单周转动力学,从而探索其机理。细菌系统已经成为这种重要酶的标准实验模型。通过对机理的了解,我们希望了解破坏性自由基是如何产生的,以及进化是如何微调机制以使这种反应最小化的。该综合体也是抗疟疾药物以及杀菌剂和杀虫剂的目标,这些药物在医药和农业中都很重要。
英文摘要
DESCRIPTION (provided by applicant): We propose to further investigate the mechanism of the bc1 complex (UQH2:cyt c2 oxidoreductase) in order to understand its role in cellular aging, and its function as the target for drugs and pest-control reagents. These latter depend on differential sensitivities to quinone-mimics that act as anti-malarial drugs, fungicides, pesti- cides, herbicides, etc., in different species. These enzymes are at the core of all major respiratory and photosynthetic pathways, and are directly responsible for about 30% of the energy conversion of the biosphere. This central importance in biology provides an intrinsic interest, relating directly to our understanding of cellular physiology, energy conversion mechanisms, and maintenance. The photosynthetic bacteria provide a model system for studying the medically important mitochondrial complex. The catalytic core of the bc1 complex is highly conserved across the mitochondrial-bacterial divide, and the reaction mechanism is essentially the same. In the bacterial system, the interplay between function and structure can be more easily studied because the system can be activated by illumination, initiating turnover in the 10 <s time scale. In addition, the bacte- rial system is readily amenable to molecular engineering through specific mutagenesis. The research supported by this grant has contributed substantially to our understanding of how these complexes function. We take advantage of 35 years of experience in assaying function to explore the mechanism through a multi-pronged approach exploiting the synergy between molecular engineering, biophysical assay, structural studies by X-ray crystallography, detailed analysis of local structure through spectroscopy, and modeling through computer simulation. The molecular architecture of the complex that is emerging from these studies provides one of the most detailed descriptions of a molecular machine of this complexity currently available. The availability of crystallographic structures has stimulated much interest, and has provided strong support for the modified Q- cycle we proposed, which is generally accepted as the underlying mechanism. However, the structures have also provoked some interesting questions, mainly relating to unexpected dynamic features, including a large scale domain movement, and a more subtle local molecular ballet that allows rapid turnover without damaging bypass reactions. In this proposal, we address some of the more controversial issues, including features of the mechanism that minimize production of precursors of the damaging reactive oxygen species that lead to cellular suffocation. The proposal is for continuation of work on one of the key enzymes of metabolism, the bc1 complex (ubihydroquinone -cytochrome c oxidoreductase). Mitochondria power the cell through oxidation of metabolites, using the respiratory chain to pass electrons to O2. The bc1 complex is the central enzyme of the chain. A design defect from its evolutionary past has left this complex with an ability to generate damaging oxygen radicals that harm the cell. We study the same enzyme in Rhodobacter sphaeroides, a photosynthetic bacterium close to the bacterial ancestor of the mitochondria. Because the enzyme can be activated through the photosynthetic machinery, it is much easier to study rapid, single-turnover kinetics, and hence to probe the mechanism. The bacterial system has become a standard experimental model for this important enzyme. By understanding the mechanism, we hope to understand how the damaging radicals are generated, and how evolution has fined-tuned the mechanism so as to minimize this reaction. The complex is also a target for anti- malarial drugs, and for fungicides and pesticides, important both in medicine and agriculture.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REDOX TITRATION OF BC1 COMPLEX BY CD SPECTROMETER
-
批准号:7181181
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2005
-
负责人:ANTONY R. CROFTS
-
依托单位:
REDOX TITRATION OF BC1 COMPLEX BY CD SPECTROMETER
-
批准号:6977577
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2004
-
负责人:ANTONY R. CROFTS
-
依托单位:
Structure around reaction intermediates in bc1 complex
-
批准号:6401738
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2001
-
负责人:ANTONY R. CROFTS
-
依托单位:
Structure around reaction intermediates in bc1 complex
-
批准号:6642199
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2001
-
负责人:ANTONY R. CROFTS
-
依托单位:
Structure around reaction intermediates in bc1 complex
-
批准号:6530103
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2001
-
负责人:ANTONY R. CROFTS
-
依托单位:
MOLECULAR ARCHITECTURE OF UQH2: CYTC2 OXIDOREDUCTASE
-
批准号:6342797
-
项目类别:
-
资助金额:$24.76万
-
财政年份:1999
-
负责人:ANTONY R. CROFTS
-
依托单位:
MOLECULAR ARCHITECTURE OF UQH2: CYTC2 OXIDOREDUCTASE
-
批准号:6043557
-
项目类别:
-
资助金额:$28.69万
-
财政年份:1999
-
负责人:ANTONY R. CROFTS
-
依托单位:
Molecular architecture of UQH2:cyt c2 oxidoreductase
-
批准号:7374043
-
项目类别:
-
资助金额:$28.17万
-
财政年份:1999
-
负责人:ANTONY R. CROFTS
-
依托单位:
MOLECULAR ARCHITECTURE OF UQH2: CYTC2 OXIDOREDUCTASE
-
批准号:6627143
-
项目类别:
-
资助金额:$26.24万
-
财政年份:1999
-
负责人:ANTONY R. CROFTS
-
依托单位:
MOLECULAR ARCHITECTURE OF UQH2: CYTC2 OXIDOREDUCTASE
-
批准号:6489998
-
项目类别:
-
资助金额:$25.49万
-
财政年份:1999
-
负责人:ANTONY R. CROFTS
-
依托单位:
Molecular architecture of UQH2:cyt c2 oxidoreductase
-
批准号:7575661
-
项目类别:
-
资助金额:$28.36万
-
财政年份:1999
-
负责人:ANTONY R. CROFTS
-
依托单位:
Molecular architecture of UQH2:cyt c2 oxidoreductase
-
批准号:8004954
-
项目类别:
-
资助金额:$28.43万
-
财政年份:1999
-
负责人:ANTONY R. CROFTS
-
依托单位:
INSTITUTIONAL NRSA IN MOLECULAR BIOPHYSICS
-
批准号:3538365
-
项目类别:
-
资助金额:$12.71万
-
财政年份:1988
-
负责人:ANTONY R. CROFTS
-
依托单位:
INSTITUTIONAL NRSA IN MOLECULAR BIOPHYSICS
-
批准号:3538369
-
项目类别:
-
资助金额:$13.57万
-
财政年份:1988
-
负责人:ANTONY R. CROFTS
-
依托单位:
INSTITUTIONAL NRSA IN MOLECULAR BIOPHYSICS
-
批准号:3538368
-
项目类别:
-
资助金额:$15.35万
-
财政年份:1988
-
负责人:ANTONY R. CROFTS
-
依托单位:
INSTITUTIONAL NRSA IN MOLECULAR BIOPHYSICS
-
批准号:3538366
-
项目类别:
-
资助金额:$14.6万
-
财政年份:1988
-
负责人:ANTONY R. CROFTS
-
依托单位:
INSTITUTIONAL NRSA IN MOLECULAR BIOPHYSICS
-
批准号:3538367
-
项目类别:
-
资助金额:$14.51万
-
财政年份:1988
-
负责人:ANTONY R. CROFTS
-
依托单位:
MOLECULAR ARCHITECTURE OF UQH2: CYT C2 OXIDOREDUCTASE
-
批准号:3288197
-
项目类别:
-
资助金额:$15.78万
-
财政年份:1986
-
负责人:ANTONY R. CROFTS
-
依托单位:
MOLECULAR ARCHITECTURE OF UQH2:CYT C2 OXIDOREDUCTASE
-
批准号:3288200
-
项目类别:
-
资助金额:$11.22万
-
财政年份:1986
-
负责人:ANTONY R. CROFTS
-
依托单位:
MOLECULAR ARCHITECTURE OF UQH2: CYT C2 OXIDOREDUCTASE
-
批准号:3288203
-
项目类别:
-
资助金额:$16.35万
-
财政年份:1986
-
负责人:ANTONY R. CROFTS
-
依托单位:
海外基金